XML 30 R20.htm IDEA: XBRL DOCUMENT
v3.7.0.1

Condensed Consolidated Financial Statements Detail (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2017
Condensed Consolidated Financial Statements Detail [Abstract] |
Trade and Other Receivables | Trade and other receivables consisted of the following (in thousands):
|  | June 30, |  |  | December 31, |
|  | 2017 |  |  | 2016 |
Trade receivables, net |  | $ | 10,546 |  |  | $ | 474 |
Other receivables |  |  | 85 |  |  |  | 92 |
Trade and other receivables, net |  | $ | 10,631 |  |  | $ | 566 |
Property and Equipment, Net | Property and equipment, net consisted of the following (in thousands):
|  | June 30, |  |  | December 31, |
|  | 2017 |  |  | 2016 |
Equipment and furniture |  | $ | 1,921 |  |  | $ | 14,023 |
Leasehold improvements |  |  | 334 |  |  |  | 554 |
|  |  | 2,255 |  |  |  | 14,577 |
Less: Accumulated depreciation and amortization |  |  | (2,021 | ) |  |  | (13,541 | )
Property and equipment, net |  | $ | 234 |  |  | $ | 1,036 |
Accrued and Other Liabilities | Accrued and other liabilities consisted of the following (in thousands):
|  | June 30, |  |  | December 31, |
|  | 2017 |  |  | 2016 |
Accrued payroll and other benefits |  | $ | 138 |  |  | $ | 1,582 |
Accrued clinical trial costs |  |  | 389 |  |  |  | 743 |
Accrued incentive compensation |  |  | 134 |  |  |  | — |
Accrued legal and accounting fees |  |  | 641 |  |  |  | 385 |
Other |  |  | 760 |  |  |  | 1,505 |
Total |  | $ | 2,062 |  |  | $ | 4,215 |
Reconciliation of Numerator and Denominator Used in Calculation of Basic and Diluted Net Income (Loss) Per Share Available to Common Stockholders | The following is a reconciliation of the numerator (net income or loss) and the denominator (number of shares) used in the calculation of basic and diluted net income (loss) per share available to common stockholders (in thousands):
|  | Three Months Ended June 30, |  |  | Six Months Ended June 30, |
|  | 2017 |  |  | 2016 |  |  | 2017 |  |  | 2016 |
Numerator |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net income (loss) |  | $ | 285 |  |  | $ | (15,160 | ) |  | $ | (10,429 | ) |  | $ | (23,525 | )
Less: Deemed dividend on convertible preferred stock |  |  | — |  |  |  | — |  |  |  | (5,603 | ) |  |  | — |
Less: Allocation of undistributed earnings to participating securities |  |  | (113 | ) |  |  | — |  |  |  | — |  |  |  | — |
Net income (loss) available to common stockholders, basic and diluted |  | $ | 172 |  |  | $ | (15,160 | ) |  | $ | (16,032 | ) |  | $ | (23,525 | )
Denominator |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Weighted average shares outstanding used for basic net income (loss) per share available to common stockholders |  |  | 7,588 |  |  |  | 6,022 |  |  |  | 7,240 |  |  |  | 6,000 |
Effect of dilutive stock options |  |  | 55 |  |  |  | — |  |  |  | — |  |  |  | — |
Weighted average shares outstanding used for diluted net income (loss) per share available to common stockholders |  |  | 7,643 |  |  |  | 6,022 |  |  |  | 7,240 |  |  |  | 6,000 |
Outstanding Securities Considered Anti-Dilutive | Potentially dilutive securities are excluded from the calculation of diluted net income (loss) per share available to common stockholders if their inclusion is anti-dilutive. The following table shows the weighted-average outstanding securities considered anti-dilutive and therefore excluded from the computation of diluted net income (loss) per share available to common stockholders (in thousands):
|  | Three Months Ended June 30, |  |  | Six Months Ended June 30, |
|  | 2017 |  |  | 2016 |  |  | 2017 |  |  | 2016 |
Convertible preferred stock (as converted) |  |  | — |  |  |  | — |  |  |  | 3,732 |  |  |  | — |
Common stock options and RSUs |  |  | 1,138 |  |  |  | 554 |  |  |  | 1,391 |  |  |  | 544 |
Warrants for common stock |  |  | 19 |  |  |  | 917 |  |  |  | 19 |  |  |  | 914 |
Total |  |  | 1,157 |  |  |  | 1,471 |  |  |  | 5,142 |  |  |  | 1,458 |

X
- Definition Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(13)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_PropertyPlantAndEquipmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.3,4) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of accrued liabilities. + References No definition available. + Details
Name: | us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Condensed consolidated financial statements detail. + References No definition available. + Details
Name: | xoma_CondensedConsolidatedFinancialStatementsDetailAbstract
Namespace Prefix: | xoma_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration